ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,308.13
0.09%
Dow Jones
39,806.77
-0.49%
US Dollar vs MXN
16.56783
0.08%
Brent Oil
83.225
-0.37%
Bitcoin
71,002.30
-0.63%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Angion Biomedica Corporation (ANGN)

  7. Angion Biomedica Corporation (ANGN) Noticias

ANGN

Angion Biomedica (ANGN)

Angion Biomedica Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ANGN
FechaHoraFuenteTítuloSímboloCompañía
29/04/202406:00Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:ANGNAngion Biomedica Corporation
05/04/202415:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
29/03/202414:28Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ANGNAngion Biomedica Corporation
29/03/202414:26Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ANGNAngion Biomedica Corporation
29/03/202412:58Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ANGNAngion Biomedica Corporation
20/03/202415:37Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ANGNAngion Biomedica Corporation
20/03/202415:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
05/01/202415:05Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ANGNAngion Biomedica Corporation
13/11/202307:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANGNAngion Biomedica Corporation
11/08/202320:13Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ANGNAngion Biomedica Corporation
07/07/202308:17Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ANGNAngion Biomedica Corporation
14/06/202315:05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ANGNAngion Biomedica Corporation
14/06/202313:43Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ANGNAngion Biomedica Corporation
12/06/202316:13Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ANGNAngion Biomedica Corporation
05/06/202316:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANGNAngion Biomedica Corporation
05/06/202307:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANGNAngion Biomedica Corporation
01/06/202307:00GlobeNewswire Inc.Angion Biomedia Corp. Announces 1-for-10 Reverse Stock SplitNASDAQ:ANGNAngion Biomedica Corporation
24/05/202305:01Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:ANGNAngion Biomedica Corporation
10/05/202315:14Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ANGNAngion Biomedica Corporation
28/04/202315:46Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ANGNAngion Biomedica Corporation
28/04/202315:14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ANGNAngion Biomedica Corporation
17/03/202315:26Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ANGNAngion Biomedica Corporation
14/02/202315:41Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ANGNAngion Biomedica Corporation
17/01/202304:00GlobeNewswire Inc.Elicio Therapeutics and Angion Enter into Definitive Merger AgreementNASDAQ:ANGNAngion Biomedica Corporation
21/12/202220:50GlobeNewswire Inc.Angion Receives Nasdaq Notice Regarding Minimum Bid Price RequirementsNASDAQ:ANGNAngion Biomedica Corporation
15/08/202215:05GlobeNewswire Inc.Angion Provides Corporate Update and Reports Second Quarter 2022 Financial ResultsNASDAQ:ANGNAngion Biomedica Corporation
26/07/202205:17TipRanksH.C. Wainwright Reiterates Their Hold Rating on Angion Biomedica (ANGN)NASDAQ:ANGNAngion Biomedica Corporation
25/07/202215:30GlobeNewswire Inc.Angion Announces Process to Explore Strategic Alternatives for Enhancing and Preserving Shareholder ValueNASDAQ:ANGNAngion Biomedica Corporation
29/06/202215:05GlobeNewswire Inc.Angion Announces Discontinuation of Phase 2 Trial of ANG-3070 in Patients with Primary Proteinuric Kidney DiseaseNASDAQ:ANGNAngion Biomedica Corporation
27/05/202215:43Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:ANGNAngion Biomedica Corporation
 Showing the most relevant articles for your search:NASDAQ:ANGN

Su Consulta Reciente

NYSE
CVX
Chevron
AMEX
XLV
Health Care Select Sector
NYSE
KO
Coca Cola
NYSE
BAC
Bank of America
FX
EURUSD
Euro vs US Dollar
CCOM
OILBRENT
Brent Oil
CCOM
US30
US 30
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
VZ
Verizon Communications
CCOM
SILVER
SILVER
USOTC
BNPQY
BNP Paribas (QX)
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
NKE
Nike
FX
USDMXN
US Dollar vs MXN
CCOM
US500
US 500
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados